Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB652

Introduced
2/20/25  

Caption

Protecting Patients from Deceptive Drug Ads Act

Congress_id

119-S-652

Policy_area

Health

Introduced_date

2025-02-20

Companion Bills

No companion bills found.

Similar Bills

US SB882

Patients Before Middlemen Act

US SB1186

Lower Drug Costs for Families Act

US HB2554

Lower Drug Costs for Families Act

US HB950

Saving Seniors Money on Prescriptions ActThis bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

US HB2214

DRUG Act Delinking Revenue from Unfair Gouging Act

US SB529

Capping Prescription Costs Act of 2025

US HB2553

Capping Prescription Costs Act of 2025

US SB864

HELP Copays Act Help Ensure Lower Patient Copays Act